Comparison of apoptosis signaling through T cell receptor, fas, and calcium ionophore

Related Experiment Videos

H T Maecker1, S Hedjbeli, M Alzona

  • 1Department of Medicine/Oncology, Stanford University Medical Center, California 94305, USA.

Insights

Investigating apoptosis in SUP-T13 leukemia cells revealed distinct signaling pathways for different inducers. However, resistant variants suggest a common regulatory point, independent of bcl-2, p53, or c-myc expression.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • The SUP-T13 cell line is a human T leukemia model susceptible to apoptosis.
  • Apoptosis can be induced by various agents, including anti-TCR mAb, calcium ionophores, and anti-fas mAb.

Purpose of the Study:

  • To investigate the distinct signaling pathways of apoptosis induction by anti-TCR mAb, calcium ionophores, and anti-fas mAb in SUP-T13 cells.
  • To identify common regulatory mechanisms of apoptosis, particularly in resistant cell variants.

Main Methods:

  • Induction of apoptosis in SUP-T13 cells using anti-TCR mAb, A23187 (calcium ionophore), and anti-fas mAb.
  • Assessment of DNA fragmentation and cell death kinetics.
  • Rescue experiments using anti-CD3 mAb and PKC activators (PMA).
  • Analysis of bcl-2, p53, and c-myc expression in parental and resistant cell lines.

Main Results:

  • All three agents induced DNA fragmentation similarly, but cell death kinetics differed.
  • Anti-TCR mAb-induced apoptosis was rescued by anti-CD3 mAb, while anti-fas mAb-induced apoptosis was rescued by PMA.
  • Two SUP-T13 variant subclones were resistant to all three apoptosis inducers.
  • Expression levels of bcl-2, p53, and c-myc were similar in parental and variant cells and did not change significantly upon treatment.

Conclusions:

  • Apoptosis induction by anti-TCR mAb, calcium ionophores, and anti-fas mAb involves unique proximal signaling pathways.
  • A common, yet unidentified, regulatory mechanism likely controls apoptosis in SUP-T13 cells, as evidenced by resistant variants.
  • The common regulation does not appear to be mediated by bcl-2, p53, or c-myc at the protein expression level.

Related Concept Videos